HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichi Ueno Selected Research

Gap Junction beta-1 Protein

6/2008The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
8/2007Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.
3/2007Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
10/2006Connexin 32 as an anti-invasive and anti-metastatic gene in renal cell carcinoma.
5/2006Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells.
4/2005A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
2/2005Cytotoxic effect of the Her-2/Her-1 inhibitor PKI-166 on renal cancer cells expressing the connexin 32 gene.
7/2004Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichi Ueno Research Topics

Disease

15Neoplasms (Cancer)
01/2015 - 02/2002
11Pruritus (Itching)
06/2019 - 10/2009
8Renal Cell Carcinoma (Grawitz Tumor)
03/2019 - 07/2004
6Allergic Contact Dermatitis
01/2013 - 07/2011
5Inflammation (Inflammations)
02/2014 - 05/2003
5Rheumatoid Arthritis
10/2012 - 10/2005
4Kidney Neoplasms (Kidney Cancer)
01/2015 - 02/2005
4Dermatitis
01/2013 - 08/2011
3Mesothelioma
06/2017 - 08/2009
3Malignant Mesothelioma
05/2015 - 08/2009
3Type 2 Diabetes Mellitus (MODY)
01/2013 - 04/2009
3Atopic Dermatitis (Atopic Eczema)
12/2012 - 07/2011
3Osteoarthritis
10/2012 - 03/2012
3Body Weight (Weight, Body)
07/2011 - 05/2003
2Hypoxia (Hypoxemia)
07/2017 - 06/2008
2Skin Diseases (Skin Disease)
12/2012 - 07/2011
2Acute Lung Injury
12/2012 - 11/2011
2Contact Dermatitis (Eczema, Contact)
10/2011 - 08/2011
2Tuberculosis (Tuberculoses)
09/2011 - 05/2008
2Hypersensitivity (Allergy)
10/2009 - 10/2004
1Psoriasis (Pustulosis Palmaris et Plantaris)
06/2019
1Neck Pain (Cervicalgia)
01/2016
1Metabolic Diseases (Metabolic Disease)
11/2014
1Breast Neoplasms (Breast Cancer)
01/2014
1Rhinitis
12/2012
1Fever (Fevers)
10/2011
1Eczema
10/2011
1Acute Liver Failure (Fulminant Hepatic Failure)
10/2011
1Pulmonary Tuberculosis
09/2011

Drug/Important Bio-Agent (IBA)

9ConnexinsIBA
08/2009 - 07/2004
8Gap Junction beta-1 ProteinIBA
06/2008 - 07/2004
6Proteins (Proteins, Gene)FDA Link
07/2017 - 07/2002
6Messenger RNA (mRNA)IBA
02/2014 - 08/2008
6Picryl Chloride (Trinitrochlorobenzene)IBA
01/2014 - 07/2011
6Histamine (Histamine Dihydrochloride)FDA Link
01/2014 - 05/2003
5Sunitinib (Sutent)FDA Link
03/2019 - 01/2015
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2012 - 07/2011
3Nerve Growth Factor (NGF)IBA
06/2019 - 01/2008
3Pharmaceutical PreparationsIBA
03/2019 - 05/2008
3Connexin 43 (Connexin43)IBA
06/2017 - 08/2009
3Histamine H4 ReceptorsIBA
02/2014 - 10/2005
3Acetaminophen (Paracetamol)FDA LinkGeneric
10/2011 - 02/2002
3EnzymesIBA
09/2011 - 05/2008
2Peptides (Polypeptides)IBA
06/2019 - 01/2014
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2015 - 06/2011
2AntipruriticsIBA
01/2013 - 10/2009
2Anthocyanins (Anthocyanin)IBA
12/2012 - 07/2011
2GlucocorticoidsIBA
01/2012 - 08/2011
2HaptensIBA
10/2011 - 09/2011
2Cytochrome P-450 CYP2E1 (CYP2E1)IBA
10/2011 - 05/2008
2Isoniazid (Ftivazide)FDA LinkGeneric
09/2011 - 05/2008
2Vinblastine (Vinblastine Sulfate)FDA Link
06/2011 - 03/2007
2Alanine Transaminase (SGPT)IBA
03/2010 - 08/2008
2Triglycerides (Triacylglycerol)IBA
04/2009 - 08/2008
2Glucose (Dextrose)FDA LinkGeneric
04/2009 - 06/2006
2CholesterolIBA
04/2009 - 08/2008
1Imiquimod (Aldara)FDA LinkGeneric
06/2019
1trichostatin A (A 300)IBA
03/2019
1Butyric Acid (Butanoic Acid)IBA
07/2017
1Oxygen (Dioxygen)IBA
07/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2017
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
01/2015
1ElacridarIBA
01/2015
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2014
1seryl- leucyl- isoleucyl- glycyl- - arginyl- leucinamideIBA
01/2014
1p-Methoxy-N-methylphenethylamineIBA
01/2014
1Substance PIBA
01/2014
1Serotonin (5 Hydroxytryptamine)IBA
01/2014
1seryl- leucyl- isoleucyl- glycyl- arginyl- leucineIBA
01/2014
1Peptide Hydrolases (Proteases)FDA Link
01/2014
14-methylhistamineIBA
01/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2013
1plastochromanol 8IBA
10/2013
1Simvastatin (Zocor)FDA LinkGeneric
10/2013
1Atorvastatin (Lipitor)FDA Link
10/2013
1Betamethasone (Celestone)FDA Link
01/2013
1royal jellyIBA
01/2013
1CosmeticsIBA
01/2013
1Pioglitazone (Actos)FDA Link
01/2013
1hydroxide ionIBA
12/2012
1(2- hydroxy- 2- methyl- cyclopentanone- 5- ylidene)methyl- 9,10- secopregna- 5,7,10(19)- triene- 1,3- diolIBA
12/2012
1Cholecalciferol (Vitamin D3)FDA Link
12/2012
1RA 263IBA
07/2012
1Estrogen ReceptorsIBA
07/2012
1ProstaglandinsIBA
01/2012
1AntigensIBA
01/2012
1Prostaglandin D2IBA
01/2012
1Prostaglandins DIBA
01/2012
1Interleukin-8 (Interleukin 8)IBA
11/2011
1ChemokinesIBA
11/2011
1Drinking WaterIBA
10/2011
11- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
09/2011
1fexofenadine (Allegra)FDA LinkGeneric
09/2011
1InterleukinsIBA
08/2011

Therapy/Procedure

5Therapeutics
10/2011 - 10/2006
1Intradermal Injections
01/2014
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2014